CCRA Study Guide 2026
Everything you need to pass the CCRA exam in one place: the exam format, every topic to study, real practice questions with explanations, flashcards, and full-length practice tests. Free, no sign-up needed.
📋 CCRA Exam Format at a Glance
📚 CCRA Topics to Study (21)
✍️ Sample CCRA Questions & Answers
1. Dosage and safety (Find out how the medicine affects human metabolism and pharmacology).
The primary purpose of a Phase 1 clinical study is to evaluate the safety of a new drug, determine a safe dosage range, and identify potential side effects. These studies also investigate the drug's pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) in humans. This initial phase helps establish the drug's basic profile in humans.
2. When investigational product is returned from a site for destruction, the CRA must confirm:
Returned IP must be documented with quantities matching records, properly labeled, and accompanied by return authorization documentation; this ensures full accountability and proper destruction.
3. The initial recording of data for a clinical study is called __________ and comprises notes from observations, lab results, and other relevant documents.
A source document is the original record of clinical findings, observations, or other activities in a clinical trial. It includes all information, original records, and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. Examples include hospital records, clinic charts, lab results, and investigator's notes.
4. What is the PRIMARY purpose of a Site Qualification Visit (SQV) conducted by a CRA?
The SQV evaluates whether the site has adequate facilities, staff expertise, patient population, and regulatory infrastructure to successfully conduct the trial.
5. Which document type serves as the definitive guide for CRAs on how to perform site visits for a specific trial?
The Monitoring Plan specifies the monitoring strategy, methodology, responsibilities, and procedures to be followed during trial monitoring visits.
6. ICH E6(R2) defines 'essential documents' as those that individually and collectively permit evaluation of the conduct of a trial and:
Essential documents allow evaluation of both the conduct of the trial and the quality of data generated, and are required to be maintained throughout and after the trial.